Human Endogenous Retrovirus as Therapeutic Targets in Neurologic DiseaseKaren Giménez-Orenga, Elisa Oltra|Pharmaceuticals|2021Cited by 43
HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptomsKaren Giménez-Orenga, Elisa Oltra, Hervé Perron et al.|Frontiers in Immunology|2022Cited by 41
MYC Induces a Hybrid Energetics Program Early in Cell ReprogrammingJavier Prieto, Josema Torres, Jennifer Lippincott‐Schwartz et al.|Stem Cell Reports|2018Cited by 37
Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future PerspectivesKatharine A. Seton, Jesper Mehlsen, José Espejo et al.|Journal of Clinical Medicine|2024Cited by 32
Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular VesiclesAlba González–Cebrián, Elisa Oltra, Jiabao Xu et al.|Frontiers in Medicine|2022Cited by 14